Surgery Partners, Inc. $SGRY Shares Bought by Charles Schwab Investment Management Inc.

Key Points

• Charles Schwab Investment Management increased its holdings in Surgery Partners, Inc. by 6.8%, owning 890,816 shares worth approximately $21 million.
• Surgery Partners received mixed ratings from analysts, with Barclays lowering its price target to $24.00 while Bank of America initiated coverage with a buy rating and a $28.00 target.
• In the latest earnings report, Surgery Partners reported a 0.17 EPS, exceeding expectations, and demonstrated an 8.4% increase in revenue compared to the previous year.

Charles Schwab Investment Management Inc. increased its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 6.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 890,816 shares of the company's stock after acquiring an additional 56,399 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.69% of Surgery Partners worth $21,157,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. PNC Financial Services Group Inc. grew its holdings in Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock worth $28,000 after acquiring an additional 542 shares during the period. DekaBank Deutsche Girozentrale purchased a new stake in Surgery Partners during the first quarter worth $65,000. State of Wyoming boosted its position in Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its position in Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after purchasing an additional 465 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in Surgery Partners by 7,902.7% during the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock worth $211,000 after purchasing an additional 8,772 shares in the last quarter.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Bank of America assumed coverage on Surgery Partners in a research report on Monday, July 28th. They set a "buy" rating and a $28.00 target price on the stock. Barclays decreased their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 27th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Surgery Partners Trading Up 0.6%

NASDAQ SGRY traded up $0.13 during trading hours on Wednesday, hitting $22.82. 1,093,321 shares of the company's stock were exchanged, compared to its average volume of 1,689,494. The business's 50 day moving average is $22.24 and its 200-day moving average is $22.85. Surgery Partners, Inc. has a 12-month low of $18.87 and a 12-month high of $33.90. The firm has a market capitalization of $2.93 billion, a P/E ratio of -15.96 and a beta of 1.82. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm's revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.21 earnings per share. As a group, analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling

In other Surgery Partners news, Director Teresa Deluca sold 20,018 shares of the company's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares in the company, valued at $1,027,234.02. This represents a 30.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by corporate insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.